Search results for "Diol"

showing 10 items of 11756 documents

Valor pronóstico de la troponina T en pacientes hospitalizados con angina o infarto sin elevación del segmento ST

2003

Introduction and objectives. Cardiac troponins are highly specific and sensitive for detecting minimal myocardial damage. The aim of our study was to determine the prognostic value of troponinT levels in patients hospitalized for suspected angina or myocardial infarction without STsegment elevation. Patients and method. We recorded the frequency of death, acute myocardial infarction, heart failure, or need for coronary revascularization in the three months after the onset of symptoms in 346 consecutive patients admitted for suspected acute coronary syndrome, excluding those who developed myocardial infarction with persistent ST-segment elevation. Results. Serum troponin T levels were ≥ 0.1 …

Acute coronary syndromemedicine.medical_specialtyTroponin TUnstable anginabusiness.industrymedicine.diseaseChest painAnginaInternal medicineHeart failuremedicineCardiologyMyocardial infarction diagnosisMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessRevista Española de Cardiología
researchProduct

One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock

2021

Background: We aimed to evaluate the effect of intravenous glycoprotein IIb/IIIa receptor inhibitors (GPIs) on in-hospital survival and mortality during and at the 1-year follow-up in patients undergoing percutaneous coronary intervention (PCI) for myocardial infarction (MI) complicated by cardiogenic shock (CS), who were included in the Polish Registry of Acute Coronary Syndromes (PL-ACS). Methods: From 2003 to 2019, 466,566 MI patients were included in the PL-ACS registry. A total of 10,193 patients with CS received PCI on admission. Among them, GPIs were used in 3934 patients. Results: The patients treated with GPIs were younger, had lower systolic blood pressure on admission, required i…

Acute coronary syndromemedicine.medical_specialtyacute coronary syndrome; cardiogenic shock; glycoprotein IIb/IIIa receptor inhibitors; myocardial infarction; percutaneous coronary interventionmedicine.medical_treatmentArticleacute coronary syndromeInternal medicineAngioplastyRisk of mortalityMedicineMyocardial infarctionAdverse effectbusiness.industryCardiogenic shockcardiogenic shockpercutaneous coronary interventionRPercutaneous coronary interventionGeneral Medicinemedicine.diseaseglycoprotein IIb/IIIa receptor inhibitorsmyocardial infarctionConventional PCICardiologyMedicinebusinessJournal of Clinical Medicine
researchProduct

High-sensitivity troponin T and the risk of recurrent readmissions after hospitalization for acute heart failure

2017

Abstract Objectives High-sensitivity troponin is a biomarker of myocardial damage and is associated with a greater risk of mortality and disease progression in patients with acute heart failure (AHF). However, its relationship with the risk of future readmissions is less known. The aim of this study was to assess the association between ultrasensitive troponin T (TnT-us) values in patients with AHF and the risk of recurrent readmissions in the follow-up. Methods We prospectively included a cohort of 621 consecutive patients with AHF, excluding those patients with acute coronary syndrome. We measured the TnT-us levels obtained during the first medical contact in the emergency department. The…

Acute coronary syndromemedicine.medical_specialtybiologyTroponin Tbusiness.industryGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseRate ratioTroponin03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicineHeart failureCohortmedicineRisk of mortalitybiology.proteinCardiology030212 general & internal medicinebusinessRevista Clínica Española (English Edition)
researchProduct

0436: Diagnostic value of serial ultrasensible troponin I measurements for acute coronary syndrome identification in cardiac intensive care unit

2014

Introduction ACS diagnosis relies on the detection of an increase or a decrease in troponin levels (delta-TnI) that might be estimated as absolute (delta-TnI-abs) or relative value (delta-TnI-rel). The discriminative cut-off value of delta-TnI to identify ACS in patients admitted in ICU is a matter of debate. Methods We aimed to determine in a monocentric registry the cut-off value of delta-TnI to identify ACS among patients admitted in ICU with a suspicion of acute myocardial ischemia. All the patients had 2 measurements of ultrasensible cTnI (ADVIA Centaur Siemens®; 99th percentile: 0,04 μg/L). Patients were classified in 4 groups: 1) ACS (NSTEMI, UA), 2) Cardiac non coronary diseases (he…

Acute coronary syndromemedicine.medical_specialtybiologybusiness.industrymedicine.diseaseChest painmusculoskeletal systemTroponinPericarditisInternal medicineHeart failureTroponin ImedicineCoronary care unitbiology.proteinCardiologycardiovascular systemMyocardial infarctionmedicine.symptombusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases Supplements
researchProduct

2020

(1) Background: Knowledge about predictors for the long-time patency of recanalized chronic total coronary occlusions (CTOs) is limited. Evidence from invasive follow-up in the absence of acute coronary syndrome (routine surveillance coronary angiography) is scarce. (2) Methods: In a monocentric-retrospective analysis, we obtained baseline as well as periprocedural data of patients undergoing routine invasive follow-up. We defined target vessel failure (TVF) as a combined primary endpoint, consisting of re-occlusion, restenosis, and target vessel revascularization (TVR). (3) Results: We included 93 consecutive patients (15.1% female) from October 2013 to May 2018. After a follow-up period o…

Acute coronary syndromemedicine.medical_specialtybiologybusiness.industrymedicine.medical_treatmentGeneral Medicine030204 cardiovascular system & hematologyRevascularizationmedicine.diseaseTroponin03 medical and health sciences0302 clinical medicineRestenosisInternal medicineCohortmedicineClinical endpointCardiologybiology.proteinCumulative incidence030212 general & internal medicinebusinessTIMIJournal of Clinical Medicine
researchProduct

P4571PFA-100, a test of platelet adhesion/aggregation, predicts cardiovascular events after an acute coronary syndrome and can help in the decision-m…

2019

Abstract Background The dual antiplatelet therapy (DAPT) duration is a matter of great interest among cardiologists. Because of the conflicting evidences and the necessity to balance the reduction in major cardiac events (MACE) occurrence and the risk of major bleedings after an acute coronary syndrome (ACS), there is a general consensus on prolonging DAPT on an individual basis. There is less consensus on which parameters are to be evaluated. Nowadays tests of platelet reactivity are not included in the decision-making. Few data are available on the prognostic value of aspirin response tests that are sensitive to other mediators of platelet adhesion and aggregation in vivo under flow condi…

Acute coronary syndromemedicine.medical_specialtybusiness.industryInternal medicinePlatelet adhesionmedicineCardiologyDUAL (cognitive architecture)Cardiology and Cardiovascular Medicinemedicine.diseasebusinessEuropean Heart Journal
researchProduct

Impact of Diabetes and Impaired Glucose Tolerance (IGT) on Complications and Hospitalisation in Patients with Acute Coronary Syndrome

2007

Acute coronary syndromemedicine.medical_specialtybusiness.industrymedicine.diseaseImpaired glucose tolerancePharmacotherapyInternal medicineDiabetes mellitusInternal MedicinemedicineCardiologyIn patientCardiology and Cardiovascular MedicinebusinessHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Impact of dual antiplatelet therapy with proton pump inhibitors on the outcome of patients with acute coronary syndrome undergoing drug-eluting stent…

2012

This study aimed to assess if proton pump inhibitors (PPIs) may reduce the effectiveness of clopidogrel, than H2 antagonist (anti-H2) in order to determine rehospitalization for acute coronary syndrome (re-ACS), target vessel revascularization (TVR) and cardiac death. This case-control study included 176 patients with ACS undergoing angioplasty (PCI) with drug-eluting stent implantation. The population was divided into two groups: PPI group (n=121) consisting of patients receiving at discharge dual antiplatelet therapy (DAT) plus PPI and anti-H2 group (n=55), consisting of patients receiving at discharge DAT + H2 receptor antagonist (H2RA). In a followup of 36 months the prevalence of ACS e…

Acute coronary syndromemedicine.medical_specialtyeducation.field_of_studyArticle Subjectbusiness.industrymedicine.medical_treatmentPopulationmedicine.diseaseClopidogrelEsomeprazoleSurgeryantiplatelet therapy PPIs clopidogrel anti-H2 ACS PCIDrug-eluting stentInternal medicineAngioplastyConventional PCImedicineCardiologyClinical StudyeducationbusinessOmeprazolemedicine.drug
researchProduct

Retinal optical coherence tomography angiography as a biomarker of acute kidney injury after acute coronary syndrome

2018

Background Contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) is frequent and associated with long-term renal impairment and mortality. Retinal vessel density (RVD) measured by OCT-Angiography could reflect the global cardiovascular burden of ACS patients and thus provide a fast and non-invasive assessment of the systemic microcirculation, that may be involved in CIN occurrence. Methods Between October 2016 and March 2017, 452 ACS patients were admitted in our coronary care unit. Retinal OCT-A was performed within two days after PCI. Patients were divided in two groups, according to Acute kidney injury (AKI) occurrence (KDIGO …

Acute coronary syndromemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyNephropathy03 medical and health sciences0302 clinical medicineInternal medicineMedicine030212 general & internal medicine[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansComputingMilieux_MISCELLANEOUS[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyFramingham Risk Scorebusiness.industryAcute kidney injuryPercutaneous coronary interventionmedicine.disease3. Good health[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansConventional PCICoronary care unitCardiologyBiomarker (medicine)Cardiology and Cardiovascular Medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Coronary Stent Thrombosis — Predictors and Prevention

2020

BACKGROUND: Stent thrombosis (ST) is a dreaded complication after stent implantation and is associated with a mortality between 5% and 45%. The mechanisms by which ST arises are complex. Because of the seriousness of this situation, all physicians should have at least basic knowledge of it. In this article, we present the risk factors for ST and discuss some innovative approaches to its treatment. METHODS: This review is based on pertinent articles retrieved by a selective search in PubMed, and on current international guidelines and expert recommendations. RESULTS: The frequency of ST has been markedly lowered by technical advances in coronary stenting and by the implementation of modern i…

Acute coronary syndromemedicine.medical_specialtymedicine.medical_treatmentReview Article030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCoronary stentmedicineHumans030212 general & internal medicinebusiness.industryCoronary ThrombosisHazard ratioStentGeneral MedicineOdds ratiomedicine.diseaseThrombosisClinical trialCoronary arteriesmedicine.anatomical_structureCardiologyStentsbusinessDeutsches Ärzteblatt international
researchProduct